China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 675,332 | 161,750 | 338,881 | 219,337 | 183,766 |
Marketable Securities | 517,767 | 765,507 | 613,527 | 22,895 | N/A |
Receivables | 113,978 | 100,270 | 125,116 | 77,267 | 33,919 |
Inventories | 261,476 | 250,728 | 243,296 | 209,571 | 156,413 |
Other current assets | 38,109 | 0 | 0 | 45,912 | 0 |
TOTAL | $1,635,594 | $1,299,725 | $1,357,188 | $593,122 | $389,418 |
Non-Current Assets | |||||
PPE Net | 189,363 | 177,597 | 178,327 | 166,813 | 132,092 |
Investments And Advances | 18,275 | 27,538 | 15,428 | 14,904 | 10,615 |
Intangibles | 399,981 | 381,036 | 399,052 | 25,390 | 23,389 |
Other Non-Current Assets | 16,301 | 51,962 | 59,984 | 8,830 | 49,444 |
TOTAL | $623,920 | $638,133 | $652,791 | $215,936 | $215,540 |
Total Assets | $2,259,514 | $1,937,859 | $2,009,979 | $809,057 | $604,958 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 118,233 | 106,006 | 111,338 | 83,377 | 65,957 |
TOTAL | $139,006 | $119,309 | $122,349 | $97,635 | $73,441 |
Non-Current Liabilities | |||||
aiOther Non-Current Liabilities | 10,744 | 16,810 | 20,192 | 29,327 | -17,390 |
TOTAL | $38,728 | $43,698 | $42,927 | $47,097 | $10,380 |
Total Liabilities | $177,734 | $163,007 | $165,276 | $144,732 | $83,821 |
Shareholders' Equity | |||||
Shares Outstanding, K | N/A | N/A | N/A | 27,612 | 27,185 |
Common Shares | 4 | 4 | 4 | 3 | 3 |
Retained earnings | 925,576 | 773,291 | 634,483 | 506,426 | 438,483 |
Other shareholders' equity | 124,022 | 10,283 | 76,518 | 73,665 | 33,191 |
TOTAL | $2,081,780 | $1,774,852 | $1,844,703 | $664,325 | $521,137 |
Total Liabilities And Equity | $2,259,514 | $1,937,859 | $2,009,979 | $809,057 | $604,958 |